Loss of Zokufa leaves gap in sector

Humphrey Zokufa, who died at the weekend after a short illness, was an outspoken pharmacist-turned-health administrator whose career spanned the public and private sector.

He spent 11 years at the helm of the Board of Healthcare Funders (BHF), an association representing the interests of medical schemes and their administrators, before becoming registrar of the Council for Medical Schemes (CMS) in November.

His appointment by Health Minister Aaron Motsoaledi was controversial, as he effectively moved from player to referee, but in his characteristically good-natured style, he shrugged off his critics.

While he was MD of the BHF, Zokufa led a high-profile court case challenging the CMS over its interpretation of regulation 8 to the Medical Schemes Act that governs payment for prescribed minimum benefits (PMBs).

The medical schemes council maintained that medical schemes must pay for PMBs in full, regardless of what healthcare providers charged, while the BHF had lobbied to get such payments capped at rates determined by schemes.

His sudden death leaves the CMS’s board confronting the question of whether it must recruit a new registrar from scratch, or whether it can make a recommendation to the minister based on the candidates it scrutinised in 2016. That issue will be discussed at a meeting, likely to be convened ahead of the board’s next gathering in late February, according to council chairman Yosuf Veriava.

The industry will be keenly watching to see if the new registrar is as openly supportive of the minister’s plans for the National Health Insurance as Zokufa was and the extent to which they seek to protect the industry and its 8.8-million medical scheme beneficiaries.

CMS chief financial officer Daniel Lehutjo is to take up the role of acting registrar, a position he held for more than two years prior to Zokufa’s appointment.

Before he commenced his work at the BHF, Zokufa was registrar of the Medicines Control Council and worked in the Department of Health as its chief director for pharmaceutical policy and planning.

He is survived by his wife Thandi, his son as well as three daughters.